Vanneyra Chum
About Vanneyra Chum
Vanneyra Chum is a Biomanufacturing Associate II specializing in Cell Therapy at ElevateBio in Waltham, Massachusetts, where she has worked since 2021. She has a background in biology and biotechnology, with previous roles at notable institutions including Dana-Farber Cancer Institute and Apple.
Work at ElevateBio
Vanneyra Chum has been employed at ElevateBio as a Biomanufacturing Associate II, Cell Therapy since 2021. In this role, she contributes to the biomanufacturing processes related to cell therapy. ElevateBio is located in Waltham, Massachusetts, where Chum has worked for three years.
Previous Employment Experience
Before joining ElevateBio, Vanneyra Chum held several positions in the healthcare and biotechnology sectors. She worked at Dana-Farber Cancer Institute as a Cell Processing Specialist from 2019 to 2021. Prior to that, she was an Associate Scientist at Nextcea, Inc. for six months in 2018. Chum also has experience as a Specialist at Apple from 2017 to 2019 and as a Certified Medical Assistant at New England Foot & Ankle for nine years, from 2009 to 2018.
Education and Expertise
Vanneyra Chum earned her Bachelor of Science degree in Biology/Biotechnology and Biomedical Engineering/Nutrition from the University of Massachusetts Lowell. She attended the university from 2013 to 2017, completing her studies over four years. This educational background supports her expertise in biomanufacturing and cell therapy.
Background in Cell Therapy
Chum has a strong background in cell therapy, having worked in various roles related to this field. She served as a Cell Processing Specialist II at Dana-Farber Cancer Institute for three months in 2020 and as a Cell Processing Specialist from 2019 to 2021. Her experience in cell therapy includes hands-on processing and manufacturing of cellular products.
Clinical Laboratory Experience
Vanneyra Chum has clinical laboratory experience, having worked as a Clinical Laboratory Technician at Lowell General Hospital Saints Campus from 2009 to 2011. This role contributed to her foundational knowledge in laboratory practices and patient care, which complements her subsequent roles in biotechnology and cell therapy.